Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Zonneveld

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|June 29, 1995
Methotrexate for chronic diseases in adultsI M Zonneveld, J D Bos
Archives of Dermatology|October 8, 1998
Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot studyI M Zonneveld, A Rubins, S Jablonska, et al.
Acta Dermato-Venereologica|September 1, 1996
Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1M A De Rie, I M Zonneveld, L Witkamp, et al.
Archives of Dermatology|February 1, 1996
Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritisI M Zonneveld, W K Bakker, P F Dijkstra, et al.
The British Journal of Dermatology|September 1, 1996
The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimensI M Zonneveld, M A De Rie, R C Beljaards, et al.
Clinical and Experimental Immunology|April 7, 1998
Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12A Snijders, T C Van der Pouw Kraan, M Engel, et al.
The British Journal of Dermatology|July 1, 1995
Efficacy and tolerability of multiple-dose SDZ IMM 125 in patients with severe psoriasisL Witkamp, I M Zonneveld, E G Jung, et al.
Journal of the American Academy of Dermatology|June 1, 1997
Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled studyI M Zonneveld, M M Meinardi, T Karlsmark, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|June 29, 1995
Methotrexate for chronic diseases in adultsI M Zonneveld, J D Bos
Archives of Dermatology|October 8, 1998
Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot studyI M Zonneveld, A Rubins, S Jablonska, et al.
Acta Dermato-Venereologica|September 1, 1996
Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1M A De Rie, I M Zonneveld, L Witkamp, et al.
Archives of Dermatology|February 1, 1996
Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritisI M Zonneveld, W K Bakker, P F Dijkstra, et al.
The British Journal of Dermatology|September 1, 1996
The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimensI M Zonneveld, M A De Rie, R C Beljaards, et al.
Clinical and Experimental Immunology|April 7, 1998
Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12A Snijders, T C Van der Pouw Kraan, M Engel, et al.
The British Journal of Dermatology|July 1, 1995
Efficacy and tolerability of multiple-dose SDZ IMM 125 in patients with severe psoriasisL Witkamp, I M Zonneveld, E G Jung, et al.
Journal of the American Academy of Dermatology|June 1, 1997
Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled studyI M Zonneveld, M M Meinardi, T Karlsmark, et al.
Pageof 1